1. Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue: a distinctive type of B-cell lymphoma. Cancer. 1983; 52:1410–1416. PMID:
6193858.
Article
2. Isaacson P, Chott A, Nakamura S, et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymph oma). In : Swerdlow SH, Campo E, Harris NL, editors. WHO Classifi cation of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: In ternational Agency for Research on Cancer;2008. p. 214–217.
3. Song IS, Choi KW, Kim CY, et al. Clinicopathologic study of primary gastric lymphoma of B-cell lymphoma of MALT. Korean J Gastroenterol. 1998; 31:463–476.
4. Yokoi T, Nakamura T, Nakamura S. Differential diagnosis of the superficial-type gastric malignant lymphoma: differential diagnosis of gastric MALT lymphomas. Stomach Intest. 2001; 36:13–20.
5. Mehra M, Agarwal B. Endoscopic diagnosis and staging of mucosa-associated lymphoid tissue lymphoma. Curr Opin Gastroenterol. 2008; 24:623–626. PMID:
19122505.
Article
6. Suekane H, Iida M, Yao T, Matsumoto T, Masuda Y, Fujishima M. Endoscopic ultrasonography in primary gastric lymphoma: correlation with endoscopic and histologic findings. Gastrointest Endosc. 1993; 39:139–145. PMID:
8495833.
Article
7. Caletti G, Fusaroli P, Togliani T. EUS in MALT lymphoma. Gastrointest Endosc. 2002; 56(4 Suppl):S21–S26. PMID:
12297744.
Article
8. Nakamura S, Matsumoto T, Suekane H, et al. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori. Gut. 2001; 48:454–460. PMID:
11247887.
Article
9. El-Zahabi LM, Jamali FR, El-Hajj II, et al. The value of EUS in predicting the response of gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication. Gastrointest Endosc. 2007; 65:89–96. PMID:
17185085.
Article
10. Nagashima R, Takeda H, Maeda K, Ohno S, Takahashi T. Regression of duodenal mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori. Gastroenterology. 1996; 111:1674–1678. PMID:
8942749.
Article
11. Kamura M, Matsui K, Kokubo Y, et al. A case of the mucosa-associated lymphoid tissue lymphoma in the duodenal bulb improved rapidly by eradication of Helicobacter pylori for 4-years. Gastroenterol Endosc. 2000; 42:164–168.
12. Kim JS, Jung HC, Shin KH, Song IS, Kim CW, Kim CY. Eradication of Helicobacter pylori infection did not lead to cure of duodenal mucosa-associated lymphoid tissue lymphoma. Scand J Gastroenterol. 1999; 34:215–218. PMID:
10192204.
13. Fukazawa K, Sato K, Kihira K, et al. A cese of duodenal low-grade mucosa-associated lymphoid tissue lymphoma which did not respond to eradication therapy for Helicobacter pylori infection. Gastroenterol Endosc. 1999; 41:1484–1489.
14. Xiang Z, Onoda N, Ohira M, et al. Mucosa-associated lymphoid tissue lymphoma of the duodenum: report of a case resistant to Helicobacter pylori eradication. Hepatogastroenterology. 2004; 51:732–735. PMID:
15143903.
15. Woo KH, Kim JH, Yoon SB, et al. Duodenal mucosa-associated lymphoid tissue lymphoma: a case report. Korean J Intern Med. 2007; 22:296–299. PMID:
18309692.
Article
16. Bertoni F, Coiffier B, Salles G, et al. MALT lymphomas: pathogenesis can drive treatment. Oncology (Williston Park). 2011; 25:1134–1142. 1147PMID:
22229204.
17. Ruskoné-Fourmestraux A, Lavergne A, Aegerter PH, et al. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut. 2001; 48:297–303. PMID:
11171816.
18. Choi MK, Kim GH. Diagnosis and treatment of gastric MALT lymphoma. Korean J Gastroenterol. 2011; 57:272–280. PMID:
21623135.
Article
19. Matsumoto T, Iida M, Shimizu M. Regression of mucosa-associated lymphoid-tissue lymphoma of rectum after eradication of Helicobacter pylori. Lancet. 1997; 350:115–116. PMID:
9228971.
Article
20. Alkan S, Karcher D, Newman MA, Cohen P. Regression of salivary gland MALT lymphoma after treatment for Helicobacter pylori. Lancet. 1996; 348:268–269. PMID:
8684218.
Article